Reconciling Fisher and Neyman

  • David S. Salsburg
Part of the Springer Series in Statistics book series (SBH)


The major themes of the previous chapters are

  1. (1)

    The randomized controlled clinical trial is a complex scientific experiment that is expensive to run and that yields a rich lode of data.

  2. (2)

    Probability calculations can be made from data, but there is no satisfactory way of relating those probabilities to real life.

  3. (3)

    Significance testing, as developed by Fisher, is a relatively vague tool, in which probabilities are calculated as a means of rejecting null hypotheses, which are postulated as straw-men.

  4. (4)

    Significance tests must be directed against a well-defined class of alternative hypotheses that represent what is really expected to happen, and the narrower the class of alternatives, the more powerful the test.

  5. (5)

    Confidence intervals can be calculated through the use of the algoroithms of significance test, but they can be applied to randomly chosen subsets of the data without invoking the problems associated with significance test applied to subsets of patients.



Significance Test Percent Coverage Numerical Answer Construct Confidence Interval Medical Question 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag New York, Inc. 1992

Authors and Affiliations

  • David S. Salsburg
    • 1
  1. 1.Pfizer Research DivisionPfizer, Inc.GrotonUSA

Personalised recommendations